SCORE study report #11: Incidences of neovascular events in eyes with retinal vein occlusion

Ophthalmology

Volumn 118, Issue 7, 2011, Pages 1364-1372

  Chan, Clement K ^a,b   Ip, Michael S ^c   Vanveldhuisen, Paul C ^d   Oden, Neal L ^d   Scott, Ingrid U ^e   Tolentino, Michael J ^f   Blodi, Barbara A ^c  

^a Southern California Desert Retina Consultants   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d EMMES CORPORATION   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f Center for Retina and Macular Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EYE DISEASE; FEMALE; HUMAN; INTERMETHOD COMPARISON; IRIS DISEASE; IRIS NEOVASCULARIZATION; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; VITREOUS HEMORRHAGE;

AGED; CAPILLARIES; FEMALE; GLAUCOMA, NEOVASCULAR; GLUCOCORTICOIDS; HUMANS; INCIDENCE; IRIS; ISCHEMIA; LIGHT COAGULATION; LINEAR MODELS; MALE; NEOVASCULARIZATION, PATHOLOGIC; RETINAL HEMORRHAGE; RETINAL NEOVASCULARIZATION; RETINAL VEIN OCCLUSION; RETINAL VESSELS; RISK ASSESSMENT; TRIAMCINOLONE; VITREOUS HEMORRHAGE;

EID: 79959946982     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.11.020     Document Type: Article

References (29)

1. Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
2. P. Mitchell, W. Smith, and A. Chang Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study Arch Ophthalmol 114 1996 1243 1247 (Pubitemid 26338856)
3. R. Klein, S.E. Moss, S.M. Meuer, and B.E. Klein The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study Arch Ophthalmol 126 2008 513 518 (Pubitemid 351549845)
4. R. Klein, B.E. Klein, and K.E. Lee Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study Am J Ophthalmol 142 2006 539 549
5. I.U. Scott, P.C. VanVeldhuisen, N.L. Oden SCORE Study Investigator Group SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion Ophthalmology 116 2009 504 512
6. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5 Arch Ophthalmol 127 2009 1101 1114
7. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
8. I.U. Scott, and M.S. Ip It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE Study [letter] Arch Ophthalmol 123 2005 581 582 (Pubitemid 40489946)
9. P.B. Greenberg, A. Martidis, and A.H. Rogers Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion [letter] Br J Ophthalmol 86 2002 247 248 (Pubitemid 34127557)
10. M.S. Ip, J.L. Gottlieb, and A. Kahana Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion Arch Ophthalmol 122 2004 1131 1136 (Pubitemid 39031127)
11. O. Cekic, S. Chang, and J.J. Tseng Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion Retina 25 2005 851 855 (Pubitemid 41456575)
12. R.F. Degenring, B. Kamppeter, I. Kreissig, and J.B. Jonas Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion Acta Ophthalmol Scand 81 2003 548 550 (Pubitemid 37265685)
13. H.L. Brooks Jr, S. Caballero Jr, and C.K. Newell Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone Arch Ophthalmol 122 2004 1801 1807 (Pubitemid 39602140)
14. J.M. Butler, S.M. Guthrie, and M. Koc SDF-1 is both necessary and sufficient to promote proliferative retinopathy J Clin Invest 115 2005 86 93 (Pubitemid 40385508)
15. R. Lima e Silva, J. Shen, and S.F. Hackett The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization FASEB J 21 2007 3219 3230 (Pubitemid 47565540)
16. N. Arimura, H. Otsuka, and K. Yamakiri Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy Ophthalmology 116 2009 921 926
17. M.B. Grant, W.S. May, and S. Caballero Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization Nat Med 8 2002 607 612 (Pubitemid 34633439)
18. M.Z. Ratajczak, E. Zuba-Surma, and M. Kucia The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis Leukemia 20 2006 1915 1924 (Pubitemid 44614878)
19. Y. Ki-I, N. Arimura, and Y. Noda Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion Curr Eye Res 32 2007 1065 1072 (Pubitemid 351412289)
20. N. Mukaida, M. Morita, and Y. Ishikawa Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression J Biol Chem 269 1994 13289 13295
21. M. Nie, L. Corbett, A.J. Knox, and L. Pang Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists J Biol Chem 280 2005 2550 2561 (Pubitemid 40189357)
22. Manual of Policies and Procedures (MOPP) for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 4.0 2008 National Eye Institute Bethesda, MD 41 4-8; 6-1 6-10. NTIS PB2008106870
23. Protocol for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 7.0 2008 National Eye Institute Bethesda, MD 2447; 54-65. NTIS PB2008113743
24. B.A. Blodi, A. Domalpally, I.U. Scott SCORE Study Research Group Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study report 9 Arch Ophthalmol 128 2010 1140 1145
25. Early Treatment Diabetic Retinopathy Study Research Group Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11 Ophthalmology 98 1991 807 822
26. M.S. Ip, N.L. Oden, I.U. Scott SCORE Study Investigator Group SCORE Study report 3: study design and baseline characteristics Ophthalmology 116 2009 1770 1777
27. Branch Vein Occlusion Study Group Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial Arch Ophthalmol 104 1986 34 41
28. Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 1997 486 491
29. R.G. Michels, and J.D. Gass The natural course of retinal branch vein obstruction Trans Am Acad Ophthalmol Otolaryngol 78 1974 OP166 OP177